Lihua Ni

Donghu Road
Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Functional Role of ALKBH5 in Kidney Injury: Insights Into Mechanisms and Therapeutic Potential.

Functional Role of ALKBH5 in Kidney Injury: Insights Into Mechanisms and Therapeutic Potential.

Journal: Journal of cellular biochemistry

Published: June 13, 2026

Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets.

Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets.

Journal: Annals of medicine

Published: May 27, 2026

Targeting PSAT1 in diabetic kidney disease: a ferroptosis-driven strategy for precision therapy.

Targeting PSAT1 in diabetic kidney disease: a ferroptosis-driven strategy for precision therapy.

Journal: Molecular and cellular biochemistry

Published: November 19, 2025

Natural Products as Potential Therapeutic Candidates for Diabetic Kidney Disease: Molecular Mechanisms, Translational Challenges, and Future Prospects.

Natural Products as Potential Therapeutic Candidates for Diabetic Kidney Disease: Molecular Mechanisms, Translational Challenges, and Future Prospects.

Journal: International journal of molecular sciences

Published: October 19, 2025

Exercise-preconditioning attenuates TAC-induced cardiac hypertrophy and myocardial injury through activating NRF2.

Exercise-preconditioning attenuates TAC-induced cardiac hypertrophy and myocardial injury through activating NRF2.

Journal: Free radical biology & medicine

Published: June 12, 2025

Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression.

Mitochondrial dysfunction: the hidden catalyst in chronic kidney disease progression.

Journal: Renal failure

Published: May 29, 2025

UBE2M Identified by CRISPR Screening as a Key Regulator of Cisplatin-Induced Acute Kidney Injury via the p53 Pathway

UBE2M Identified by CRISPR Screening as a Key Regulator of Cisplatin-Induced Acute Kidney Injury via the p53 Pathway

Journal: Endocrine, metabolic & immune disorders drug targets

Published: April 29, 2025

EphrinB2 alleviates tubulointerstitial fibrosis in diabetic kidney disease.

EphrinB2 alleviates tubulointerstitial fibrosis in diabetic kidney disease.

Journal: Journal of translational medicine

Published: April 21, 2025

Pharmacological role of MLN4924 in cisplatin-induced acute kidney injury.

Pharmacological role of MLN4924 in cisplatin-induced acute kidney injury.

Journal: Biochimica et biophysica acta. General subjects

Published: April 02, 2025

Dissecting and validation the biomarker of heart failure progression in patients with atherosclerosis by single-cell sequencing, bioinformatics, and machine learning.

Dissecting and validation the biomarker of heart failure progression in patients with atherosclerosis by single-cell sequencing, bioinformatics, and machine learning.

Journal: Frontiers in genetics

Published: March 11, 2025

Deciphering cellular heterogeneity and pathway dynamics in urinary samples: a UMAP-Based approach to understanding acute kidney injury.

Deciphering cellular heterogeneity and pathway dynamics in urinary samples: a UMAP-Based approach to understanding acute kidney injury.

Journal: Frontiers in pharmacology

Published: February 11, 2025

Integrative approaches to depression in end-stage renal disease: insights into mechanisms, impacts, and pharmacological strategies.

Integrative approaches to depression in end-stage renal disease: insights into mechanisms, impacts, and pharmacological strategies.

Journal: Frontiers in pharmacology

Published: January 14, 2025

Showing 1-12 of 45

Last Updated: 09/26/2026